Page 701«..1020..700701702703..710720..»

Explained: India To Add Biotechnology Muscle To Its Polar Science Research – Swarajya

Posted: July 21, 2021 at 1:51 am

Biotechnological applications of polar microbes have been identified as a key focus area. Further, as highlighted in a series of tweets by MoES, the proposed centre will be be expected to investigate the relationship between climate change and the emergence of infectious diseases, derive products from nature that could be valuable to the industry, identify compounds for purposes such as preventing infections, and explore novel molecules for commercial use.

The MoES-DBT collaboration will jointly identify more thrust areas over time.

Initially, researchers will file proposals to carry out research using the existing MoES polar stations. However, joint laboratories will be set up in the future so that researchers wont have to move samples to and from laboratories in India to carry out experiments.

We have been doing research in the Arctic, Antarctic, and Himalayas the three poles but unfortunately we have not had expertise in biological sciences. DBT has the expertise, so we want to work together, Dr M Ravichandran, director of the National Centre for Polar and Ocean Research (NCPOR), told Swarajya.

Based in Goa, NCPOR is Indias premier R&D institution responsible for the countrys research activities in the polar and Southern Ocean regions. It is an autonomous body under the Ministry of Earth Sciences, which is the nodal ministry for polar research in India.

The focus of the MoES-DBT joint effort, Dr Ravichandran says, will be bioprospecting and microbiology research.

Bioprospecting is short for biodiversity prospecting. It is the systematic study of bio-resources, like plants and microorganisms, with the purpose of developing commercially valuable products for pharmaceutical, agricultural, and other applications and overall for the benefit of society.

The process of bioprospecting goes over the stages of sample collection, isolation, characterisation, and translation to product development and commercialisation, the United Nations Development Programme notes in its 2016 report on the subject.

Bioprospecting, when properly regulated, generates revenues that can be directly linked to the conservation of biodiversity and to the benefit of local communities, the report says.

With eyes on bioprospecting and other research in biology, India aims to add biotechnology muscle to the science it carries out in the polar region.

We want to encourage polar, cold-climate biotechnology study to strengthen the area of polar research, Dr Ravichandran says.

Research in polar biology has been underway at a small scale in India. The work is done by very few people and usually includes researchers from different universities and institutes whose proposals get accepted by NCPOR.

The Centre for Cellular and Molecular Biology, Wildlife Institute of India, Zoological Survey of India, and Banaras Hindu University are among the institutes that have carried out long-term programmes in areas like microbiology and wildlife ecology at the poles.

Much of the biology research over the last decade has involved the study of bacterial diversity and adaptability in snow and ice, both in terrestrial and marine environments in the region.

However, there is now a sense that India can do more in polar biology.

The regions around the North and South Poles north of the Arctic, or south of the Antarctic Circles, respectively are important natural laboratories for scientific research.

Much of the land and marine expanse within this region still remains unexplored and therein lies the opportunity for researchers to find answers to scientific questions.

Indias engagement with the polar regions goes back a long time. It began with the signing of the Svalbard Treaty in February 1920 to initiate formal ties with the Arctic. Getting started with the Antarctic region took longer, but began eventually when India launched its first Antarctic expedition in 1981.

Now, four decades later, India set off on its 40th scientific expedition to Antarctica in January 2021.

More:
Explained: India To Add Biotechnology Muscle To Its Polar Science Research - Swarajya

Posted in Biotechnology | Comments Off on Explained: India To Add Biotechnology Muscle To Its Polar Science Research – Swarajya

Agricultural Biotechnology Market Share 2021 Global Trend, Segmentation, Size, Business Growth, Top Key Players Analysis Industry, Opportunities and…

Posted: July 21, 2021 at 1:51 am

The Detailed Market intelligence report on the Global Agricultural Biotechnology Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Agricultural Biotechnology Market place for the forecast 2021 2027.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Get Sample Report:@ https://industrystatsreport.com/Request/Sample?ResearchPostId=11569&RequestType=Sample

Scope Of The Report:

Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Agricultural Biotechnology Market.

Key Benefits for Agricultural Biotechnology Market Reports

Agricultural Biotechnology Market Segmentation:

Segmentation by Type:

PlantsAnimalsMicrobes

Segmentation by Application:

Vaccine DevelopmentTransgenic Crops & AnimalsAntibiotic DevelopmentNutritional SupplementsFlower CulturingBiofuels

By Region

Agricultural Biotechnology Market Key Players:

KWS SAAT SE & Co. KGaAChemChinaCortevaLimagrainMITSUI & CO., LTD.Evogene Ltd.Bayer AGValent BioSciences LLCNufarmMarrone Bio InnovationsPerformance Plants Inc.ADAMA Ltd

Table of Content

1. Chapter Report Methodology1.1. Research Process1.2. Primary Research1.3. Secondary Research1.4. Market Size Estimates1.5. Data Triangulation1.6. Forecast Model1.7. USPs of Report1.8. Report Description

2. Chapter Global Agricultural Biotechnology Market Overview: Qualitative Analysis

2.1. Market Introduction2.2. Executive Summary2.3. Global Agricultural Biotechnology Market Classification2.4. Market Drivers2.5. Market Restraints2.6. Market Opportunity2.7. Agricultural Biotechnology Market: Trends2.8. Porters Five Forces Analysis2.8.1. Bargaining Power of Suppliers2.8.2. Bargaining Power of Consumers2.8.3. Threat of New Entrants2.8.4. Threat of Substitute Product and Services2.8.5. Competitive Rivalry within the Industry2.9. Market Attractiveness Analysis2.9.1. Market Attractiveness Analysis by Segmentation2.9.2. Market Attractiveness Analysis by Region

3. Chapter Global Agricultural Biotechnology Market Overview: Quantitative Analysis

3.1. Global Agricultural Biotechnology Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 20273.2. Global Agricultural Biotechnology Market Revenue Market Share (%), 2014- 20273.3. Global Agricultural Biotechnology Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 20273.4. Global Agricultural Biotechnology Market Sales Market Share (%), 2014- 2027

4. Chapter Global Agricultural Biotechnology Market Analysis: Segmentation By Type

5. Chapter Global Agricultural Biotechnology Market Analysis: Segmentation By Application

6. Chapter Global Agricultural Biotechnology Market Analysis: By Manufacturer

6.1. Global Agricultural Biotechnology Market Revenue (USD Million), by Manufacturer, 2014 20276.2. Global Agricultural Biotechnology Market Share (%), by Manufacturer, 20186.3. Global Agricultural Biotechnology Market Sales (Number of Units), by Manufacturer, 2014 20276.4. Global Agricultural Biotechnology Market Share (%), by Manufacturer, 20186.5. Global Agricultural Biotechnology Market Price (USD/Unit), by Manufacturer, 2014 20276.6. Global Agricultural Biotechnology Market Revenue Growth Rate (%), by Manufacturer, 2014 20276.7. Merger & Acquisition6.8. Collaborations and Partnership6.9. New Product Launch

7. Chapter Agricultural Biotechnology Market: Regional Analysis

This comprehensive report will provide:

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Get Full Report: @ https://industrystatsreport.com/Agriculture/Premium-Research-On-Agricultural-Biotechnology-Market-Growth/Summary

About us: Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us atsales@brandessenceresearch.com

Read more from the original source:
Agricultural Biotechnology Market Share 2021 Global Trend, Segmentation, Size, Business Growth, Top Key Players Analysis Industry, Opportunities and...

Posted in Biotechnology | Comments Off on Agricultural Biotechnology Market Share 2021 Global Trend, Segmentation, Size, Business Growth, Top Key Players Analysis Industry, Opportunities and…

Recognizing the Signs of Diabetes Can Save Lives – Pharmacy Times

Posted: July 21, 2021 at 1:49 am

Diabetes means that the body either does not make enough insulin or cannot use the insulin it makes effectively. This leads to a buildup of glucose in the blood and can lead to serious health issues.

Approximately 34.2 million adults in the United States have diabetes, according to the CDC.

Diabetes is the seventh-leading cause of death in the United States and the No. 1 cause of adult blindness, kidney failure, and lower-limb amputations. Unfortunately, the number of adults who have received a diagnosis of diabetes has more than doubled in the past 20 years.1

There are 3 main types of diabetes: type 1 diabetes (T1D), type 2 diabetes (T2D), and gestational diabetes.

T1D is most common in children, adolescents, and young adults. T1D is thought to be caused by an autoimmune reaction in the pancreas, and it usually develops quickly. This type of diabetes cannot be prevented and requires lifelong insulin therapy.1

T2D results when the body does not use insulin effectively. This is usually found in adults and develops over many years. Approximately 90% to 95% of individuals who receive a diagnosis of diabetes have T2, which can be delayed or prevented with healthy lifestyle changes.1

Gestational diabetes develops during pregnancy in patients who have never had diabetes before. This usually subsides after pregnancy, but it increases the risk for T2D later in life in both the child and the mother.1

During the development of T2D, there is a syndrome called prediabetes when the blood glucose levels are higher than normal but not high enough to be diagnosed as T2D. If lifestyle changes do not take place, the development of T2D is imminent.1

Diabetes Signs and Symptoms

Prediabetes very often does not have signs or symptoms. Their absence often causes prediabetes to go undetected until serious health problems, such as T2D, occur. Some individuals with prediabetes, however, experience blurred vision, excess hunger, fatigue, frequent urination, and increased thirst.2,3 Another possible sign of prediabetes is the darkening of skin in certain areas, including the armpits, elbows, knees, knuckles, and neck.4

T1D signs and symptoms can appear suddenly and are often subtle but can become severe. These include the following5-7:

Bedwetting: An increased need to urinate can cause bedwetting in a child who has been dry at night.

Blurry vision: High blood glucose levels affect the tiny blood vessels in the eyes, causing fluid to seep into the lens of the eye.

Dry mouth: High blood glucose levels tend to decrease saliva flow.

Extreme thirst: This is tied to high blood glucose levels and exacerbated by frequent urination.

Fatigue: The body feels as if it does not have enough energy due to improper insulin activity.

Frequent infections of the skin, urinary tract, or vagina: High blood glucose levels cause white blood cells to have difficulty traveling. This lowers the bodys ability to fight off infections.

Irritability and mood changes: Fluctuations in blood glucose levels can wreak havoc with moods.

Polyphagia or increased hunger: This is especially pronounced after eating. Because the body cannot absorb glucose, it is constantly looking for more fuel.

Polyuria or frequent urination: When kidneys cannot process the high amount of glucose, they allow some glucose to go into the urine, causing a higher volume of urine.

Unexplained weight loss: The blood excretes extra glucose into the urine, causing weight loss even though the patient is eating more.

Upset stomach and vomiting: Nerve damage may prevent the body from moving food from the stomach to the intestines in an efficient manner. Food can then build up in the stomach and cause nausea and vomiting.

Signs of an emergency that may require immediate medical attention include abdominal pain, breath that smells fruity, confusion, loss of consciousness, rapid breathing, and shaking.6

T2D has signs and symptoms similar to those of T1D with a few important differences, including:

Slow-healing sores: Blood glucose can build up on the inside of arteries, causing them to narrow. This can restrict the amount of nutrients and oxygen being delivered to help repair damage.7

Neuropathy: The nerves are starved for nutrients and oxygen, causing nerve damage. This can be an extremely painful condition. There are 4 types of neuropathies associated with diabetes: autonomic neuropathy affecting the internal organs, such as the eyes or heart; focal neuropathy affecting a single nerve, such as those in the hands, head, legs, or torso; peripheral neuropathy, affecting the feet and legs and sometimes the arms and hands; and proximal neuropathy, which is very rare, affecting the buttocks, hips, or thighs.8

Most pregnant women do not experience signs or symptoms of gestational diabetes. The only way to know is if a patient has the condition is to perform a blood glucose test, typically given at 24 to 28 weeks gestation. However, some women may have dry mouth, fatigue, and increased thirst.9

Pharmacists can be on the lookout by evaluating the questions patients ask, reviewing medication histories, and doing a visual assessment. Pharmacists can also remind patients to get annual physicals that include laboratory work for glycated hemoglobin A1c. Signs and symptoms may go unnoticed until a serious condition develops, but pharmacists can do their part to help the growing incidence of diabetes.

Pharmacists can also promote eating healthy foods and getting regular exercise, as well as recommend weight-loss regimens that have been proven to decrease the risk of developing T2D, such as the Mediterranean or Paleolithic diets.

Kathleen Kenny, PharmD, RPh, has more than 25 years of experience as a community pharmacist and is a freelance clinical medical writer based in Colorado Springs, Colorado.

REFERENCES

Read more from the original source:
Recognizing the Signs of Diabetes Can Save Lives - Pharmacy Times

Posted in Diabetes | Comments Off on Recognizing the Signs of Diabetes Can Save Lives – Pharmacy Times

JDRF and the Association of Diabetes Care & Education Specialists announce new partnership – PRNewswire

Posted: July 21, 2021 at 1:49 am

NEW YORK, July 20, 2021 /PRNewswire/ --JDRF, the leading global funder of Type 1 diabetes research, and the Association of Diabetes Care & Education Specialists, the largest organization dedicated to diabetes care and education specialists, proudly announce a new partnership. Together, the organizations seek to support the diabetes community through educational programs and resources to improve patient/healthcare professional dialogue and health outcomes.

"As an organization rooted in family, JDRF is excited to partner with the team at ADCES to continue supporting and enriching the T1D community," says Kristin Jahnke, JDRF director of community engagement. "By collaborating with healthcare providers throughout the ADCES network, we can increase the accessibility of our newly diagnosed resources and educational programs to serve the T1D community across the U.S.."

Utilizing the collaborative networks of both organizations, the partnerships aim to increase recipients of the JDRF Bag of Hope and the JDRF Teen and Adult No Limits care kits. Both organizations also hope to equip more healthcare professionals with the knowledge and tools to strengthen the relationship between those with Type 1 diabetes and healthcare providers.

"Diabetes care and education specialists are the front line in person-centered, quality care. We are honored to work with ADCES members and JDRF to support children and adults with Type 1 diabetes," said Kate Thomas, ADCES chief advocacy and external affairs officer. "Through this partnership, we hope to build bridges between healthcare professionals and the people with diabetes whom they serve. Together, we can improve outcomes and well-being for all."

JDRF and ADCES are committed to offering resources to help educate healthcare providers and support those with Type 1 diabetes throughout all stages of life. Health disparities affect numerous populations, including members of the diabetes community. It disproportionately affects Black, Hispanic, and Native American people and those living in rural and underserved communities. This collaboration will help both organizations reach a broader audience and offer resources to meet the needs of diverse communities.

About JDRFJDRF's mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).

About the Association of Diabetes Care & Education Specialists: ADCES is an interdisciplinary professional membership organization dedicated to improving prediabetes, diabetes and cardiometabolic care through innovative education, management and support. With more than 12,000 professional members including nurses, dietitians, pharmacists and others, ADCES has a vast network of practitioners working to optimize care and reduce complications. ADCES offers an integrated care model that lowers the cost of care, improves experiences and helps its members lead so better outcomes follow. Learn more at DiabetesEducator.org, or visit us on Facebookor LinkedIn(Association of Diabetes Care & Education Specialists), Twitter (@ADCESdiabetes) and Instagram(@ADCESdiabetes).

SOURCE JDRF; Association of Diabetes Care & Education Specialists

View original post here:
JDRF and the Association of Diabetes Care & Education Specialists announce new partnership - PRNewswire

Posted in Diabetes | Comments Off on JDRF and the Association of Diabetes Care & Education Specialists announce new partnership – PRNewswire

The first saliva test to measure glucose levels in people with diabetes will be available in 2023 – Entrepreneur

Posted: July 21, 2021 at 1:49 am

With this new method, patients with diabetes will avoid the pain of current blood tests. In addition, this technology could be used to measure at least 130 indicators of the organism.

Stay informed and join our daily newsletter now!

July19, 20213 min read

Currently, people living with diabetes must prick their finger with a lancet once or several times a day to measure blood glucose , but this is about to change. Researchers at the University of Newcastle in Australia developed the first saliva test to measure sugar levels in diabetic patients , which could be available to the general public in 2023.

Research leader Paul Dastoor detailed in a statement that "the world's first painless diabetes test" uses a natural enzyme called glucose oxidase, as well as a powerful sensor that detects glucose in saliva.

The reaction produced by the interaction of the organic compound and saliva generates a weak electrical current that is perceptible to the sensor. When measured, the captured signals accurately reveal glucose levels. Users will be able to store the data and share it through a smartphone app.

It should be noted that glucose concentrations in saliva are 100 times lower than those found in blood. Hence the complexity of creating a device capable of perceiving this particular marker.

To make matters worse, the researchers say their technology could be used to measure at least 130 other indicators of the body . For example, tumor, hormonal and allergen markers, "which means that it will be widely applicable to detect a variety of substances that identify a number of diseases," they note. In fact, scientists are already collaborating with Harvard University to develop a non-invasive test for Covid-19 .

Another interesting fact is that these powerful and delicate biosensors are about the size of a stick of gum. For now they are produced on a small scale at the university with the help of an old wine label printer, modified to produce electronic or 'functional' devices.

The project already has state financing of about 4.6 million dollars, part of which will be used for the construction of the first factory of the device, which will begin in the coming months. It is estimated that the first commercial batch of saliva tests for diabetes will be ready in the year 2023 , something that could benefit about 460 million diabetic patients in the world.

See the original post here:
The first saliva test to measure glucose levels in people with diabetes will be available in 2023 - Entrepreneur

Posted in Diabetes | Comments Off on The first saliva test to measure glucose levels in people with diabetes will be available in 2023 – Entrepreneur

Health officials further examine correlation between HIV and diabetes – KGBT-TV

Posted: July 21, 2021 at 1:49 am

EDINBURG, Texas (KVEO) South Texas has a high rate of obesity and Type 2 diabetes within the United States.

Dr. Srinivas Mummidi and Dr. Juan Carlos Lopez-Alvarenga were two of the many local health officials that worked in a recent study showing a rise in Type 2 diabetes for people living with HIV in Rio Grande Valley.

The research on HIV and Type 2 diabetes was conducted using data from over 1,800 registries.

Dr. Mummidi said there was an interest in knowing whether diabetes was at higher risk for those with HIV but said it is important to know that the relation between the two is not a surprise.

The connection for HIV and diabetes has been known for a while because the earlier regimens that were being used actually caused a lot of metabolic problems, he said.

Dr. Mummidi said more research needs to be done to better understand the correlation.

According to Dr. Juan Carlos Lopez-Alvarenga, understanding ones genetics is important in order for everyone to maintain good health.

However, it is strongly encouraged for Hispanics to be careful with food choices because of high metabolic issues.

Dr. Lopez-Alvarenga said educating ourselves about our family genetics should be a priority to help prevent any health risks.

Its important for the youngest to know about their parents and to know to prepare

Lopez-Alvarenga expressed that if one takes the necessary precautions, it will help bring down high rates and lead people towards a healthier life.

Follow this link:
Health officials further examine correlation between HIV and diabetes - KGBT-TV

Posted in Diabetes | Comments Off on Health officials further examine correlation between HIV and diabetes – KGBT-TV

How Diabetics Should Treat Cuts and Scrapes – Diabetes, Health Topics – Hackensack Meridian Health

Posted: July 21, 2021 at 1:49 am

July 16, 2021

If you have diabetes, even a minor cut or scrape can turn into a serious problem. Heres how to treat a wound properly to protect your health.

For most people, a nick or a scrape is no big deal. But for someone with diabetes, even a minor cut or scrape can turn into a very serious problem if not treated properly.

Diabetes impacts white blood cell function, which obstructs the bodys ability to fight bacteria and close wounds, says Asaad H. Samra, M.D., director of the Center for Wound Healing at Bayshore Medical Center. In addition, people with uncontrolled diabetes may develop poor circulation, making it difficult for the body to deliver nutrients to injured areas, which hinders the healing process.

Thats why its crucial for people with diabetes to correctly treat any wound, no matter how minor it seems. Heres some advice from Dr. Samra:

Wash the wound thoroughly. Use an antibacterial soap and warm water to clean out the wound. Then pat dry with a clean cloth and apply over-the-counter antibacterial ointment.

Cover the wound. Use a bandage to keep the wound clean, moist and protected. Its now considered old, inaccurate information to let a wound dry out, says Dr Samra.

Redress it daily. Take off the bandage and make sure nothing has significantly changed since the last time you saw the wound. Use soap and water to wash away the old ointment, then pat dry and apply a fresh coat. If, after a few days, you feel the wound is healing well, you can stretch the redressing to every other day.

Inspect it every time you change the bandage. If you dont see improvement over the course of a week, or if any redness or foul smell develops, call your doctor. Also contact your doctor if the wound fails to heal within four to six weeks.

Check your feet daily. Diabetes can lead to neuropathy, which limits sensation in the extremities. So someone with diabetes could have an injury on their foot and not even know it, says Dr. Samra. This, plus poor blood flow, puts you at risk for developing an infection from a foot sore. Be on the lookout for any cuts, sores, blisters, swelling or any changes to the skin or nails. Dont forget to check the bottom of your feet (use a mirror). And never go barefoot, even inside your house.

Next Steps & Resources:

The material provided through HealthU is intended to be used as general information only and should not replace the advice of your physician. Always consult your physician for individual care.

View original post here:
How Diabetics Should Treat Cuts and Scrapes - Diabetes, Health Topics - Hackensack Meridian Health

Posted in Diabetes | Comments Off on How Diabetics Should Treat Cuts and Scrapes – Diabetes, Health Topics – Hackensack Meridian Health

Kaplan USMLE Step 3 prep: Shortness of breath in woman with diabetes – American Medical Association

Posted: July 21, 2021 at 1:49 am

If youre preparing for the United States Medical Licensing Examination (USMLE) Step 3 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check outall posts in this series.

The AMA selected Kaplan as a preferred provider to support you in reaching your goal of passing the USMLE or COMLEX-USA.AMA members can save 30% on access to additional study resources, such as Kaplans Qbank and High-yield courses. Learn more.

This months stumper

A 69-year-old woman with a 15-year history of type 2 diabetes mellitus presents to the emergency department with shortness of breath for two hours. There is no chest pain, diaphoresis, dizziness, or nausea. Past medical history is significant for diabetic foot ulcers. She has been postmenopausal for the past 18 years. Her blood pressure is 125/80 mm Hg, pulse is 70 beats per minute, and respirations are 15 breaths a minute.

On physical examination, there is a third heart sound present, but the rate and rhythm are normal. There are rales at the bilateral lung bases, but there is no wheezing or rhonchi. A chest radiograph reveals a normal mediastinum and a fine interstitial infiltrate with pleural effusions. The next step in evaluating this patient is to:

A. Order a complete blood count.

B. Order an echocardiogram.

C. Order an electrocardiogram.

D. Perform a stress treadmill test.

E. Send her for pulmonary function tests.

The correct answer is C.

Kaplan Medical explains why

Patients with diabetes are prone to silent ischemiathat is myocardial infarction without chest pain due to neuropathy. Furthermore, some postmenopausal women who are not on hormone replacement therapy are at a higher risk of cardiac disease in comparison to women who take hormones.

A 2007 study showed women receiving estrogen alone hormone-replacement therapy resulted in fewer events related to coronary heart disease (CHD) if initiated between the ages of 50 and 59 years or within 10 years after menopause. An electrocardiogram is the most important initial test for myocardial infarction. Cardiac enzymes (creatinine kinase, troponin) must also be obtained serially to rule out myocardial infarction.

Why the other answers are wrong

Choice A: This patient has no evidence of pneumonia on the chest radiograph. The patient's presentation is not consistent with pneumonia. Acute onset of shortness of breath is not consistent with pneumonia. A complete blood count would be routinely ordered in the work up of ischemia, however.

Choice B: An echocardiogram is necessary for the work up of congestive heart failure, but it is of limited use in evaluating cardiac ischemia. This test may be necessary if an acute myocardial infarction is ruled out.

Choice D: A stress or exercise treadmill test may be necessary to work up cardiac ischemia once an acute myocardial infarction is ruled out.

Choice E: A pulmonary function test will probably be necessary in the future if no cardiac ischemia is detected, and interstitial lung disease is suspected. This test may be necessary to work up cardiac ischemia once an acute myocardial infarction is ruled out.

For more prep questions on USMLE Steps 1, 2 and 3, viewother posts in this series.

Continue reading here:
Kaplan USMLE Step 3 prep: Shortness of breath in woman with diabetes - American Medical Association

Posted in Diabetes | Comments Off on Kaplan USMLE Step 3 prep: Shortness of breath in woman with diabetes – American Medical Association

Finerenone Receives FDA Approval for Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes – Pharmacy Times

Posted: July 21, 2021 at 1:49 am

The FDA has approved finerenone for the treatment of adult patients with chronic kidney disease associated with type 2 diabetes.

The FDA has approved finerenone (Kerendia, Bayer) for the treatment of adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D). Finerenone is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained estimated glomerular filtration rate decline, kidney failure, cardiovascular death, non-fatal myocardial infarction and hospitalization for heart failure. It is also the first and only nonsteroidal MRA that has been approved for use in this patient population.

The FDA approval was based on the results from the phase 3 FIDELIO-DKD trial, which demonstrated positive kidney and cardiovascular outcomes in patients with CKD associated with T2D. The approval also follows the previously granted priority review designation by the FDA.

The patient population included in the trial that supported the approval of Kerendia were at risk of chronic kidney disease progression despite receiving standard of care treatment to control blood pressure and blood glucose, said lead study investigator George Bakris, MD, University of Chicago, in a press release. In people with chronic kidney disease associated with type 2 diabetes, physicians now have a new treatment to provide kidney protection.

Currently, many patients with CKD associated with T2D are at risk for CKD progression and the occurrence of cardiovascular events. Known to be a leading cause of end-stage kidney disease, T2D can cause patients to need dialysis or a kidney transplant in order to stay alive. Additionally, Black and Hispanic American patients have been found to have increased rates of kidney failure in comparison to white patients.

Chronic kidney disease associated with type 2 diabetes can have such a debilitating impact on patients lives. Unfortunately, this disease is far reaching, as up to 40% of all patients with type 2 diabetes develop chronic kidney disease, said kidney transplant patient Kevin Longino, CEO, National Kidney Foundation, in the press release. It is important for physicians and patients to have new treatment options that can slow chronic kidney disease progression.

Finerenone has been found to be successful in this patient population because of its ability to block the overactivation of the mineralocorticoid receptor, which is thought to contribute to fibrosis and inflammation. If fibrosis and inflammation occurs, these issues can lead to permanent kidney damage.

Kerendia is the first and only nonsteroidal mineralocorticoid receptor antagonist proven to significantly slow chronic kidney disease progression and reduce cardiovascular risk in people with chronic kidney disease associated with type 2 diabetes, said Amit Sharma, MD, vice president of cardiovascular and renal, Bayer US Medical Affairs, in the press release. We are excited to bring this new kidney-focused treatment to people living with this condition.

Currently, finerenone is planned to be available in the United States at the end of July 2021. Additionally, finerenone has been submitted by Bayer for marketing authorization in the European Union.

REFERENCE

Bayers KERENDIA (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes. Whippany, NJ: Bayer; July 10, 2021. https://www.businesswire.com/news/home/20210709005441/en. Accessed July 20, 2021.

The rest is here:
Finerenone Receives FDA Approval for Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes - Pharmacy Times

Posted in Diabetes | Comments Off on Finerenone Receives FDA Approval for Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes – Pharmacy Times

Women with diabetes and hypertension don’t receive recommended pre-pregnancy counseling – UC Berkeley Public Health – UC Berkeley School of Public…

Posted: July 21, 2021 at 1:49 am

Guidelines from the CDC, American Diabetes Association, and the American College of Obstetricians and Gynecologists recommend providers offer women with diabetes or hypertension pre-pregnancy health counseling to mitigate the increased maternal and infant risk associated with both conditions. However, not much is known about how many women actually receive this important counseling.

Pre-pregnancy counseling is counseling a woman receives from their health care provider in one or many visitscounseling can cover a variety of topics. For women with diseases like diabetes or hypertension, these counseling sessions can offer the information a woman needs to care for herself and any future children before pregnancy or even before conception.

Through PRAMS, the CDC asks women to provide responses a year after birth to see if they received one or all of four types of pre-pregnancy counseling: counseling on folic acid, too much of which can cause neural defects in infants; a discussion on whether a woman desired to get pregnant; birth control counseling; and how to prepare for a healthy pregnancy. The study revealed that less than half the women reported receiving the recommended pre-pregnancy counseling. This shows a lack of care for women with these conditions and a need for evidence-based and patient-centered models of pre-pregnancy counseling for those with diabetes and hypertension, according to the study.

Previous studies have found that womenregardless of whether they have diabetes or hypertensionare less likely to know about their care and risk before or during pregnancy, regardless of age, race, whether they had been pregnant before. Black and Latina women of reproductive age are particularly impacted by diabetes and hypertension. The studys data found that of the women surveyed, 18.51% non-Hispanic Black women had diabetes alone, 33.7% had hypertension alone, and 12.11% had both hypertension and diabetes. Of those Hispanic women surveyed, 29.23% of women had diabetes alone, 16.16% had hypertension alone, and 13.2% had both hypertension and diabetes.

The model used by physicians for pre-pregnancy counseling depends, according to Marshall, on how physicians are given options for patient-centered care.

Marshall hopes to expand her research to include the development of a decision-support tool that would allow patients to determine what they need from their physician before their visit. She is also looking to expand her study to include women who may have experienced stillbirths or deliveries other than live birth, a cross section of women missing from the dataset used in the paper.

Im an interventionist which means Im always trying to get to a point where we can develop, implement and evaluate methods that can improve healthcare delivery. So given my interest, its helpful to see where things are now, says Marshall.

Study co-authors included Berkeley Public Healths Zille Huma, MPH, MBBS, and Julianna Deardorff, PhD, and Laura E. Britton, PhD, RN, of Columbia University School of Nursing.

View the full study

Go here to see the original:
Women with diabetes and hypertension don't receive recommended pre-pregnancy counseling - UC Berkeley Public Health - UC Berkeley School of Public...

Posted in Diabetes | Comments Off on Women with diabetes and hypertension don’t receive recommended pre-pregnancy counseling – UC Berkeley Public Health – UC Berkeley School of Public…

Page 701«..1020..700701702703..710720..»